Showing results (3011-3020 of 6,182) with videos related to
Sort By:
Pageof 619
Nature Medicine|May 6, 2024
APOE4 homozygozity represents a distinct genetic form of Alzheimer's diseaseJuan Fortea, Jordi Pegueroles, Daniel Alcolea, et al.Nature Medicine|May 14, 2024
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim resultsJeffrey Sevigny, Olga Uspenskaya, Laura Dean Heckman, et al.Nature Medicine|May 14, 2024
Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trialKohei Shitara, Yung-Jue Bang, Satoru Iwasa, et al.Nature Medicine|May 9, 2024
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitisMolly Fisher Thomas, Kamil Slowikowski, Kasidet Manakongtreecheep, et al.Nature Medicine|May 7, 2024
Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trialKate M Bermingham, Inbar Linenberg, Lorenzo Polidori, et al.Nature Medicine|April 30, 2024
Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer developmentRaúl Y Tito, Sara Verbandt, Marta Aguirre Vazquez, et al.Nature Medicine|April 29, 2024
Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023Jeffrey V Lazarus, Trenton M White, Katarzyna Wyka, et al.Nature Medicine|October 16, 2023
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trialJohn M Kirkwood, Michele Del Vecchio, Jeffrey Weber, et al.Nature Medicine|October 16, 2023
Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trialStephen A Harrison, Rebecca Taub, Guy W Neff, et al.Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.Pageof 619